Log In
Print this Print this

Topical INCB18424

  Manage Alerts
Collapse Summary General Information
Company Incyte Corp.
DescriptionTopical janus kinase-1 (JAK-1) and janus kinase-2 (JAK-2) inhibitor
Molecular Target Janus kinase-1 (JAK-1) ; Janus kinase-2 (JAK-2)
Mechanism of ActionJanus kinase-2 (JAK-2) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPsoriasis
Indication DetailsTreat psoriasis
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today